Acadia director receives 2026 stock awards

Bernhard Jason reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bernhard Jason reported acquisition or exercise transactions in this Form 4 filing.

Acadia Healthcare Company, Inc. director Jason Bernhard reported two stock awards of common stock on May 6, 2026. The filings show grants of 5,124 shares and 6,331 shares at a stated price of $0.00 per share, indicating compensation awards rather than open-market purchases.

Footnotes explain that the shares will vest over a three-year period in equal yearly installments beginning May 6, 2027, and that one award reflects Mr. Bernhard’s election to receive his 2026 annual cash retainer as a director in shares of common stock.

Insider Trade Summary

Grant/Award: 11,455 shares

Grant/Award 2 txns

Insider Bernhard Jason

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,331	$0.00	$0.00
Grant/Award	Common Stock	5,124	$0.00	$0.00

Holdings After Transaction: Common Stock — 45,359 shares (Direct)

Footnotes (2)

1. F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
2. F2. Reflects Mr. Bernhard's election to receive his annual cash retainer as a director for 2026 in shares of common stock.

Key Figures

Stock award 1: 5,124 shares common stock Stock award 2: 6,331 shares common stock Direct holdings after grant: 45,359 shares +3 more

6 metrics

Stock award 1 5,124 shares common stock Grant reported on May 6, 2026

Stock award 2 6,331 shares common stock Grant reported on May 6, 2026

Direct holdings after grant 45,359 shares Direct ownership after one reported award

Alternate direct holdings after grant 40,235 shares Direct ownership after the other reported award

Vesting period 3 years Shares vest in equal yearly installments

Vesting start date May 6, 2027 First installment of multi-year vesting schedule

Key Terms

Form 4, Grant, award, or other acquisition, annual cash retainer, vest

4 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

annual cash retainer financial

"election to receive his annual cash retainer as a director for 2026"

vest financial

"Shares will vest over a 3-year period in equal yearly installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Acadia Healthcare (ACHC) director Jason Bernhard report in this Form 4?

Director Jason Bernhard reported receiving two awards of Acadia Healthcare common stock on May 6, 2026. The transactions covered 5,124 shares and 6,331 shares, both recorded at $0.00 per share, indicating they were equity compensation grants rather than market purchases.

How many Acadia Healthcare (ACHC) shares were granted to Jason Bernhard?

The Form 4 shows two separate grants of Acadia Healthcare common stock to director Jason Bernhard. One grant was for 5,124 shares and the other for 6,331 shares. Both are reported as compensation-related acquisitions with a transaction price of $0.00 per share.

How do the new stock awards affect Jason Bernhard’s Acadia (ACHC) holdings?

After one of the reported grants, Jason Bernhard held 45,359 Acadia Healthcare common shares directly. After the other grant, he held 40,235 shares directly. These figures reflect updated direct ownership positions reported for each respective award in the filing.

What is the vesting schedule for Jason Bernhard’s new Acadia (ACHC) shares?

The filing states that the awarded shares will vest over a three-year period. Vesting occurs in equal yearly installments beginning May 6, 2027, meaning portions of the award become fully owned each year over that three-year schedule, rather than all at once.

Why did Jason Bernhard receive Acadia Healthcare (ACHC) shares instead of cash?

A footnote explains that one of the awards reflects Jason Bernhard’s election to receive his 2026 annual cash retainer as a director in shares of common stock. This converts a cash retainer into equity-based compensation, aligning part of his pay with company stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 05:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bernhard Jason

(Last) (First) (Middle)

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		6,331(1)	A	$0.0	40,235	D
Common Stock	05/06/2026		A		5,124(2)	A	$0.0	45,359	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

2. Reflects Mr. Bernhard's election to receive his annual cash retainer as a director for 2026 in shares of common stock.

	/s/ Brian Farley as Attorney in Fact for Jason R. Bernhard	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)